Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
LEVEST RETARD 150 mg CAPSULAS DE LIBERACION PROLONGADA EFG
Capsule
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- VENLAFAXINA HIDROCLORURO — 150 mg
- Pharmaceutical form Home Med Cabinet grouping
- Capsule
- Availability in Spain
- No packs currently marketed
Packs
LEVEST RETARD 150 mg CAPSULAS DE LIBERACION PROLONGADA EFG, 30 cápsulas
30 pcs
National code
Not marketed660883Strength of this pack 150 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 69759Official data
- Marketing authorisation holder
- TEVA PHARMA S.L.U.Official data
- Authorised
- Apr 21, 2008Official data
- Authority form code
- 36Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.